This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Coronavirus drug patented in Russia
Rospatent has registered a drug for coronavirus, invented by scientists from the Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency (FMBA) of Russia. The development has no foreign analogues.
According to the FMBA press services, the original drug dalargin was used to treat stomach ulcers, acute pancreatitis, and pancreatic necrosis. However, scientists noted that this medicine allows damaged tissues to heal, and also participates in organizing the body's immune response to viruses.
The active substance Hexapeptide Tyr-D-Ala-Gly-Phe-Leu-Arg is a completely domestic development. A new dosage form based on it was named "leitragin". The main feature of the drug is that it suppresses the so-called cytokine storm - a massive release of inflammatory substances. Because of this, more severe disorders develop with coronavirus. The prognosis in patients who have begun to develop this immune response is often poor.
The most effective form of the new drug is inhalation. All components of the new drug will be produced in Russia. After the completion of clinical trials, mass production of the drug will begin.